The usefulness of toluidine staining as a diagnostic tool for precancerous and cancerous oropharyngeal and oral cavity lesions;Utilità della colorazione con toluidina nella diagnosi delle lesioni precancerose e cancerose dell'orofaringe e del cavo orale

Acta Otorhinolaryngologica Italica

Volumn 29, Issue 4, 2009, Pages 187-190

  Allegra, E ^a   Lombardo, N ^a   Puzzo, L ^b   Garozzo, A ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

Author keywords

Malignant tumours; Oral cavity; Oropharynx; Precancerous lesions

Indexed keywords

DIAGNOSTIC AGENT; TOLONIUM CHLORIDE;

ADULT; AGED; ARTICLE; FEMALE; HUMAN; MALE; MIDDLE AGED; MOUTH; OROPHARYNX TUMOR; PATHOLOGY; PRECANCER; PREDICTION AND FORECASTING; PREVALENCE; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; MALE; MIDDLE AGED; MOUTH; OROPHARYNGEAL NEOPLASMS; PRECANCEROUS CONDITIONS; PREDICTIVE VALUE OF TESTS; PREVALENCE; TOLONIUM CHLORIDE;

EID: 73349126432     PISSN: 0392100X     EISSN: 1827675X     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Jemal A, Thimas A, Murray T, Thun M. Cancer statistics, 2002. CA Cancer J Clin 2002;52:181-2.
2. Woolgar JA, Scott J, Vaughan ED, Brown JS, West CR, Rogers S. Survival, metastasis and recurrence of oral cancer in relation to pathological features. Ann R Coll Surg Engl 1995;77:325-31.
3. World Health Organization Collaborating Center for Oral Precancerous Lesions. Definition of leukoplakia and related lesions: an aid to studies on oral precancer. Oral Surg Oral Med Oral Pathol 1978;46:518-39.
4. Banoczy J, Sugar L. Longitudinal studies on oral leukoplakia. J Oral Pathol 1972;1:265-9.
5. Chiesa F, Tradati N, Sala L, Costa L, Podrecca S, Baracchi P, et al. Follow-up of oral leukoplakia after carbon dioxide laser surgery. Arch Otolaryngol Head Neck Surg 1990;116:177-80.
6. Silverman S Jr, Gorsky M, Lozada F. Oral leukoplakia and malignant tranformation. Cancer 1984;53:563-8.
7. Onofre MA, Spoto MR, Navarro CM. Reliability of toluidine blue application in the detection of oral epithelial dysplasia and in situ and invasive squamous cell carcinomas. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001;91:535-40.
8. Epstein JB, Feldman R, Dolor RJ, Porter SR. The utility of tolonium chloride rinse in the diagnosis of recurrent or second primary cancers in patients with prior upper aerodigestive tract cancer. Head Neck 2003;25:911-21.
9. Martin IC, Kerawala CJ, Reed M. The application of toluidine blue as a diagnostic adjunct in the detection of epithelial dysplasia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998;85:444-6.
10. Epstein JB, Oakley C, Millner A, Emerton S, van der Meij E, Le N. The utility of toluidine blue application as a diagnostic aid in patients previously treated for upper oropharyngeal carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997;83:537-47.
11. Siddiqui IA, Faooq MU, Siddiqui RA. Role of toluidine blue in early detection of oral cancer. Pak J Med Sci 2006;22:184-7.
12. Marshberg A. Re-evaluation of toluidine blue application as a diagnostic adjunct in the detection of asymptomatic oral squamous cell carcinoma: a continuing prospective study of oral cancer. Cancer 1980:46:758-63.
13. Niebel HH, Chomet B. In vivo staining for the delineation of oral intraepithelial neoplastic change. J Am Dent Assoc 1964:68:801-6.
14. Portugal LG, Wilson KM, Biddinger PW, Gluckman JL. The role of toluidine blue in assessing marginal status after resection of squamous cell carcinomas of the upper aerodigestive tract. Arch Otolaryngol Head Neck Surg 1996:122:517-9.
15. Kerawala CJ, Beale V, Reed M, Martin IC. The role of vital tissue staining in the marginal control of oral squamous cell carcinoma. Int J Oral Maxillofac Surg 2000;29:32-5.
16. Gale N, Pilch BZ, Sidransky D. Epithelial precursor lesions. In: Barnes L, Eveson J, Reichart P, Sidransky D, editors. World Health Organization classification of tumours: pathology and genetics of tumours of the head and neck. Lyon: IARC Press; 2005-17.
17. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1996. CA Cancer J Clin 1996;46:5-27.
18. National Cancer Institute of Canada. Canadian Cancer Statistics 1995:18-19.
19. Sheps SB, Schechter MT. The assessment of diagnostic tests. A survey of current medical research. JAMA 1984;252:2418-22.
20. Sackett DL, Haynes RB, Tugwell P, Guyart GH. Clinical epidemiology: a basic science for clinical medicine. Boston: Little, Brown and Company; 1991. p. 69-152.
21. Gupta A, Singh M, Ibrahim R, Mehrotra R. Utility of toluidine blue staining and brush biopsy in precancerous and cancerous lesions. Acta Cytol 2007;51:788-94.
22. Epstein JB, Sciubba J, Silverman S Jr, Sroussi HY. Utility of toluidine blue in oral premalignant lesions and squamous cell carcinoma: continuing research and implications for clinical practice. Head Neck 2007;29:948-58.
23. Zhang L, Williams M, Poh CF, Laronde D, Epstein JB, Durham S, et al. Toluidine blue staining identifies high-risk primary oral premalignant lesions with poor outcome. Cancer Res 2005;65:8017-21.